Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis

Clinical trial NCT04156984 · COMPLETED

Trial details

NCT number: NCT04156984
Sponsor: David Drobne
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2021-04-07
Primary completion: 2024-06-18
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.